After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of PTC Therapeutics Inc is $2.11B. A total of 0.77 million shares were traded on the day, compared to an average of 1.08M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, PTCT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 23 BUYs and 42 SELLs from insiders. Insiders purchased 224,728 shares during that period but sold 198,281.
In the most recent transaction, Boulding Mark Elliott sold 794 shares of PTCT for 27.25 per share on Jan 30. After the transaction, the EXEC. VP AND CLO now owns 71,189 company shares. In a previous transaction on Jan 30, Almstead Neil Gregory sold 618 shares at 27.25 per share. PTCT shares that CHIEF TECHNICAL OPS OFFICER owns now total 61,202.
Among the insiders who sold shares, Pauwels Eric disposed of 366 shares on Jan 30 at a per-share price of $27.25. This resulted in the CHIEF BUSINESS OFFICER holding 44,181 shares of PTCT after the transaction. In another insider transaction, Utter Christine Marie sold 318 shares at $27.25 per share on Jan 30. Company shares held by the SVP, CHIEF ACCOUNTING OFFICER now total 35,528.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for PTCT in the last 3 months, the mean price target is $27.83 with high estimates of $45.00 and low estimates of $15.00. In terms of 52-week highs and lows, PTCT has a high of $59.84 and a low of $17.53.
As of this writing, PTCT has an earnings estimate of $0.5 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $1.47 per share and a lower estimate of -$1.1. The company reported an EPS of -$2.66 in the last quarter, which was -114.50% lower than expectations of -$1.24.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PTCT’s latest balance sheet shows that the firm has $773.38M in Cash & Short Term Investments as of fiscal 2021. There were $535.38M in debt and $509.35M in liabilities at the time. Its Book Value Per Share was -$8.89, while its Total Shareholder’s Equity was $1.44M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PTCT is Buy with a score of 3.14.
